These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24271138)

  • 1. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
    Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis.
    Qu X; Wang K; Dong W; Shen H; Wang Y; Liu Q; Du J
    Sci Rep; 2016 Feb; 6():20149. PubMed ID: 26831765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary
    Beird HC; Lin D; Lazar AJ; Futreal PA
    J Pathol; 2024 Jun; 263(2):131-134. PubMed ID: 38482738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Genetic Variants in Exon 4 of TP53 in Lung Carcinoma and in Silico Prediction of Their Significance.
    Prasad R; Sharma K; Bhutani K; Prasad S; Manhas S; Kishan J
    Indian J Clin Biochem; 2024 Apr; 39(2):276-282. PubMed ID: 38577139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk: a case control study in a Chinese population.
    Li Y; Chang SC; Niu R; Liu L; Crabtree-Ide CR; Zhao B; Shi J; Han X; Li J; Su J; Cai L; Yu S; Zhang ZF; Mu L
    BMC Cancer; 2013 Dec; 13():607. PubMed ID: 24369748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals.
    Ren J; Wang Y; Liu C; Yang L; Men X; Qiu Z
    Eur J Med Res; 2023 Nov; 28(1):478. PubMed ID: 37924162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case-cohorts within a Japanese prospective study.
    Nakano S; Yamaji T; Katagiri R; Sawada N; Inoue M; Tsugane S; Iwasaki M;
    Cancer Sci; 2022 Dec; 113(12):4385-4393. PubMed ID: 36083231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 Gene Polymorphisms and Occupational Skin Cancer Risks for Workers of Glass Fiber Manufacture.
    Mukhammadiyeva GF; Karimov DO; Bakirov AB; Karimova LK
    Iran J Public Health; 2017 Nov; 46(11):1495-1501. PubMed ID: 29167767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
    Zhao Y; Varn FS; Cai G; Xiao F; Amos CI; Cheng C
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):86-95. PubMed ID: 29141854
    [No Abstract]   [Full Text] [Related]  

  • 11. State of Art of Cancer Pharmacogenomics in Latin American Populations.
    López-Cortés A; Guerrero S; Redal MA; Alvarado AT; Quiñones LA
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D Receptor Gene FOKI Polymorphism Contributes to Increasing the Risk of HIV-Negative Tuberculosis: Evidence from a Meta-Analysis.
    Xu C; Tang P; Ding C; Li C; Chen J; Xu Z; Mao Y; Wu M; Zhao J
    PLoS One; 2015; 10(10):e0140634. PubMed ID: 26485279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
    Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
    Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis.
    Bianco A; Chiefari E; Nobile CG; Foti D; Pavia M; Brunetti A
    PLoS One; 2015; 10(8):e0136077. PubMed ID: 26296198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.
    Cui JW; Li W; Han FJ; Liu YD
    Transl Lung Cancer Res; 2015 Jun; 4(3):275-86. PubMed ID: 26207215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AXIN2 rs2240308 polymorphism contributes to increased cancer risk: evidence based on a meta-analysis.
    Wu Z; Sun Y; Tang S; Liu C; Zhu S; Wei L; Xu H
    Cancer Cell Int; 2015; 15():68. PubMed ID: 26161041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TP53 codon 72 Pro/Pro genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.
    Wang X; Hao LR; Yue K
    Int J Clin Exp Med; 2015; 8(3):3120-6. PubMed ID: 26064201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Gamma +874T/A Polymorphism Increases the Risk of Hepatitis Virus-Related Diseases: Evidence from a Meta-Analysis.
    Sun Y; Lu Y; Li T; Xie L; Deng Y; Li S; Qin X
    PLoS One; 2015; 10(5):e0121168. PubMed ID: 25939029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis.
    Sun Y; Lu Y; Pen Q; Li T; Xie L; Deng Y; Qin A
    Tumour Biol; 2015 Jun; 36(6):4555-64. PubMed ID: 25649976
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.